Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1976 2
1978 1
1979 1
1982 1
1983 1
1984 1
1986 1
1987 1
1992 3
1993 5
1994 1
1995 4
1996 2
1998 2
1999 3
2000 2
2001 1
2002 2
2004 1
2005 2
2006 1
2007 1
2008 1
2009 5
2010 7
2011 5
2012 8
2013 10
2014 9
2015 5
2016 12
2017 11
2018 6
2019 12
2020 17
2021 14
2022 7
2023 7
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Malcioln
Page 1
Review of methods for detecting glycemic disorders.
Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, Ceriello A, Rhee M, Phillips LS, Chung S, Cravalho C, Jagannathan R, Monnier L, Colette C, Owens D, Bianchi C, Del Prato S, Monteiro MP, Neves JS, Medina JL, Macedo MP, Ribeiro RT, Filipe Raposo J, Dorcely B, Ibrahim N, Buysschaert M. Bergman M, et al. Diabetes Res Clin Pract. 2020 Jul;165:108233. doi: 10.1016/j.diabres.2020.108233. Epub 2020 Jun 1. Diabetes Res Clin Pract. 2020. PMID: 32497744 Free PMC article. Review.
However, there is currently no international consensus for diagnosing prediabetes with HbA1c or glucose measurements based upon American Diabetes Association (ADA) and the World Health Organization (WHO) criteria that identify different populations at risk for progressing …
However, there is currently no international consensus for diagnosing prediabetes with HbA1c or glucose measurements based upon American Dia …
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algül H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, … See abstract for full author list ➔ Klionsky DJ, et al. Autophagy. 2016;12(1):1-222. doi: 10.1080/15548627.2015.1100356. Autophagy. 2016. PMID: 26799652 Free PMC article. No abstract available.
Tirzepatide Immunogenicity on Pharmacokinetics, Efficacy, and Safety: Analysis of Data From Phase 3 Studies.
Mullins GR, Hodsdon ME, Li YG, Anglin G, Urva S, Schneck K, Bardos JN, Martins RF, Brown K, Calderon B. Mullins GR, et al. J Clin Endocrinol Metab. 2024 Jan 18;109(2):361-369. doi: 10.1210/clinem/dgad532. J Clin Endocrinol Metab. 2024. PMID: 37700637 Free PMC article.
Maximum ADA titers ranged from 1:20 to 1: 81 920 among TE ADA+ patients. ...More TE ADA+ patients experienced hypersensitivity reactions or injection site reactions than TE ADA- patients. ...
Maximum ADA titers ranged from 1:20 to 1: 81 920 among TE ADA+ patients. ...More TE ADA+ patients experienced hypersens …
Beyond humanization and de-immunization: tolerization as a method for reducing the immunogenicity of biologics.
De Groot AS, Terry F, Cousens L, Martin W. De Groot AS, et al. Expert Rev Clin Pharmacol. 2013 Nov;6(6):651-62. doi: 10.1586/17512433.2013.835698. Expert Rev Clin Pharmacol. 2013. PMID: 24164613 Free PMC article. Review.
Immune responses to some monoclonal antibodies (mAbs) and biologic proteins interfere with their efficacy due to the development of anti-drug antibodies (ADA). In the case of mAbs, most ADA target 'foreign' sequences present in the complementarity determining region …
Immune responses to some monoclonal antibodies (mAbs) and biologic proteins interfere with their efficacy due to the development of anti-dru …
Immune Tolerance-Adjusted Personalized Immunogenicity Prediction for Pompe Disease.
De Groot AS, Desai AK, Lelias S, Miah SMS, Terry FE, Khan S, Li C, Yi JS, Ardito M, Martin WD, Kishnani PS. De Groot AS, et al. Front Immunol. 2021 Jun 16;12:636731. doi: 10.3389/fimmu.2021.636731. eCollection 2021. Front Immunol. 2021. PMID: 34220802 Free PMC article. Clinical Trial.
The goal of this study was to develop a tool for personalized immunogenicity risk assessment (PIMA) that quantifies T cell epitopes that differ between nGAA and rhGAA using information about an individual's native GAA gene and their HLA DR haplotype, and to use this information t …
The goal of this study was to develop a tool for personalized immunogenicity risk assessment (PIMA) that quantifies T cell epitopes that dif …
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAID.
Bouhnik Y, Pineton de Chambrun G, Lambert J, Nachury M, Seksik P, Altwegg R, Vuitton L, Stefanescu C, Nancey S, Aubourg A, Serrero M, Filippi J, Desseaux K, Viennot S, Abitbol V, Boualit M, Bourreille A, Giletta C, Buisson A, Roblin X, Dib N, Malamut G, Amiot A, Fumery M, Louis E, Elgharabawy Y, Peyrin-Biroulet L; MICA-GETAID Study Group. Bouhnik Y, et al. Clin Gastroenterol Hepatol. 2023 Dec;21(13):3365-3378.e5. doi: 10.1016/j.cgh.2023.01.013. Epub 2023 Jan 31. Clin Gastroenterol Hepatol. 2023. PMID: 36731588 Free article.
METHODS: A multicenter, prospective study was conducted in biologic-naive patients with CD with resolved intra-abdominal abscess treated with ADA with a 2-year follow-up. The primary endpoint was ADA failure at week (W) 24 defined as a need for steroids after W12, i …
METHODS: A multicenter, prospective study was conducted in biologic-naive patients with CD with resolved intra-abdominal abscess treated wit …
Patient's Perception of Digital Symptom Assessment Technologies in Rheumatology: Results From a Multicentre Study.
Knitza J, Muehlensiepen F, Ignatyev Y, Fuchs F, Mohn J, Simon D, Kleyer A, Fagni F, Boeltz S, Morf H, Bergmann C, Labinsky H, Vorbrüggen W, Ramming A, Distler JHW, Bartz-Bazzanella P, Vuillerme N, Schett G, Welcker M, Hueber AJ. Knitza J, et al. Front Public Health. 2022 Feb 22;10:844669. doi: 10.3389/fpubh.2022.844669. eCollection 2022. Front Public Health. 2022. PMID: 35273944 Free PMC article. Clinical Trial.
The median time patients spent assessing symptoms was 180, 7, and 8 min, respectively using online using search engines, Ada and Rheport. 111/275 (40.4%), 266/600 (44.3%) and 395/600 (65.8%) of patients rated the respective symptom assessment as very helpful or helpful, us …
The median time patients spent assessing symptoms was 180, 7, and 8 min, respectively using online using search engines, Ada and Rhep …
173 results